JPMorgan cuts target to EUR 28.50 for Solvay stock

Published on 10/27/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 2026 underlying EBITDA reached EUR 173.00 million. Solvay stock costs EUR 23.83 on October 27, 2026, up 2.19 percent versus the Xetra close.

Analyst target and earnings date

JPMorgan cut its Solvay target to EUR 28.50 from EUR 30.00 on October 20, 2026.
Solvay reported underlying EBITDA of EUR 173.00 million for the third quarter of 2026.
Solvay stock costs EUR 23.83 at Lang & Schwarz on October 27, 2026 at 4:11 p.m. CEST, 2.19 percent above the Xetra close of October 26, 2026.
Solvay is scheduled to publish complete third-quarter results on November 4, 2026.

Solvay, BE0003470755, Illustration mit AI erstellt.

JPMorgan cut its Solvay target to EUR 28.50 from EUR 30.00 on October 20, 2026, while keeping an Overweight rating, according to Markets Insider. The target lies 19.60 percent above the EUR 23.83 price. Solvay stock was trading at EUR 23.83 at Lang & Schwarz on October 27, 2026 at 4:11 p.m. CEST, up 2.19 percent versus the Xetra close of October 26, 2026.

Preliminary EBITDA reached EUR 173.00 million

Solvay reported underlying net sales of EUR 1.03 billion, underlying EBITDA of EUR 173.00 million and free cash flow of EUR 54.00 million from continuing operations for the third quarter of 2026. The figures were preliminary and were published on October 19, 2026, in the company's release, which linked the performance to the Middle East conflict and the shutdown of a peroxide plant in Saudi Arabia. The release is available from Solvay.

Guidance now spans EUR 720.00 million

The company lowered its underlying EBITDA outlook for full-year 2026 to EUR 720.00 million to EUR 740.00 million, compared with the previous EUR 770.00 million to EUR 850.00 million range. Free cash flow guidance for continuing operations stands at EUR 120.00 million to EUR 150.00 million, compared with at least EUR 200.00 million previously. The updated guidance was published on October 19, 2026, in the same Solvay release.

Results date puts the target in context

Solvay said complete third-quarter results would be published on November 4, 2026. That date gives investors the next scheduled checkpoint for the preliminary figures and the revised full-year outlook. The company is listed on Euronext Brussels and Paris under the symbol SOLB, and its operations span soda ash, peroxides, silica and specialty chemicals.

Stock price and investor view

JPMorgan's revised target remains above the Lang & Schwarz price, but the company must now convert the preliminary third-quarter numbers into completed results. The updated guidance range and the November 4 reporting date are the next measurable reference points.

The further course of trading is shown by the continuously updated real-time quote of Solvay stock.